Prestige Consumer Healthcare Inc (PBH)
70.44
+0.12
(+0.17%)
USD |
NYSE |
May 10, 16:00
70.44
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Enterprise Value: 4.627B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 4.627B |
| May 08, 2024 | 4.604B |
| May 07, 2024 | 4.608B |
| May 06, 2024 | 4.611B |
| May 03, 2024 | 4.611B |
| May 02, 2024 | 4.674B |
| May 01, 2024 | 4.667B |
| April 30, 2024 | 4.699B |
| April 29, 2024 | 4.698B |
| April 26, 2024 | 4.635B |
| April 25, 2024 | 4.618B |
| April 24, 2024 | 4.618B |
| April 23, 2024 | 4.672B |
| April 22, 2024 | 4.601B |
| April 19, 2024 | 4.595B |
| April 18, 2024 | 4.529B |
| April 17, 2024 | 4.513B |
| April 16, 2024 | 4.515B |
| April 15, 2024 | 4.519B |
| April 12, 2024 | 4.523B |
| April 11, 2024 | 4.571B |
| April 10, 2024 | 4.558B |
| April 09, 2024 | 4.570B |
| April 08, 2024 | 4.543B |
| April 05, 2024 | 4.569B |
| Date | Value |
|---|---|
| April 04, 2024 | 4.600B |
| April 03, 2024 | 4.583B |
| April 02, 2024 | 4.609B |
| April 01, 2024 | 4.695B |
| March 28, 2024 | 4.738B |
| March 27, 2024 | 4.742B |
| March 26, 2024 | 4.710B |
| March 25, 2024 | 4.690B |
| March 22, 2024 | 4.773B |
| March 21, 2024 | 4.804B |
| March 20, 2024 | 4.779B |
| March 19, 2024 | 4.788B |
| March 18, 2024 | 4.791B |
| March 15, 2024 | 4.843B |
| March 14, 2024 | 4.811B |
| March 13, 2024 | 4.863B |
| March 12, 2024 | 4.817B |
| March 11, 2024 | 4.839B |
| March 08, 2024 | 4.795B |
| March 07, 2024 | 4.741B |
| March 06, 2024 | 4.681B |
| March 05, 2024 | 4.673B |
| March 04, 2024 | 4.709B |
| March 01, 2024 | 4.618B |
| February 29, 2024 | 4.590B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.156B
Minimum
Mar 23 2020
4.863B
Maximum
Mar 13 2024
3.979B
Average
4.086B
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
| iBio Inc | 16.42M |
| Theriva Biologics Inc | -13.29M |
| Oragenics Inc | 4.605M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 53.05M |
| Revenue (Quarterly) | 282.74M |
| Total Expenses (Quarterly) | 195.91M |
| EPS Diluted (Quarterly) | 1.06 |
| Gross Profit Margin (Quarterly) | 55.86% |
| Profit Margin (Quarterly) | 18.76% |
| Earnings Yield | -2.33% |
| Operating Earnings Yield | 9.91% |
| Normalized Earnings Yield | -2.328 |